1. Metabolic agents ($22.5 billion). These drugs accounted for nearly a quarter of all Medicare beneficiary prescription drug spending. On average, metabolic agents cost $98 dollars per prescription. Nearly 60 percent of Medicare beneficiaries had a prescription for a metabolic agent.
Read the full article on Becker’s Hospital Review.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
